Literature DB >> 12123553

A prospective epidemiological study on tinea pedis and onychomycosis in Hong Kong.

Sauyi Cheng1, Laiyin Chong.   

Abstract

OBJECTIVE: To study the epidemiology of foot diseases, including tinea pedis and onychomycosis in clinic attendees in Hong Kong.
METHODS: Two groups were included: the institutional group consisted of clinical evaluation and mycological investigations by dermatologists; and the private group consisted of clinical evaluation only by the private physicians. Patients who had a regular visit to the clinics were randomly invited to have a clinical examination of their feet.
RESULTS: A total of 1014 patients were studied. The prevalence rate of foot disease, fungal infections, tinea pedis and toe nail onychomycosis were respectively 50.7%, 26.9%, 20.4% and 16.6%. More male and elderly patients were affected except that the sex prevalence in toe nail onychomycosis was not shown to be significant. Vascular disease, diabetes mellitus and obesity were the three most prevalent predisposing factors in foot disease, fungal disease and fungal nail disease. Dermatophytes, in particular Trichophyton rubrum, were shown to be the most common pathogen in both skin and nail infections.
CONCLUSIONS: Foot diseases, especially tinea pedis and toe nail onychomycosis, are common in patients attending local clinics in Hong Kong. Both physicians and patients should be more aware of foot problems and have more active approaches and management strategies.

Entities:  

Mesh:

Year:  2002        PMID: 12123553

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  10 in total

Review 1.  Athlete's foot.

Authors:  Fay Crawford
Journal:  BMJ Clin Evid       Date:  2009-07-20

2.  A prospective epidemiologic survey on the prevalence of onychomycosis and dermatophytosis in male boarding school residents.

Authors:  Zulal Erbagci; Almila Tuncel; Yasemin Zer; Iclal Balci
Journal:  Mycopathologia       Date:  2005-04       Impact factor: 2.574

3.  Analysis of dermatomycoses in Lanzhou district of northwestern China.

Authors:  Niu Tao-Xiang; Luo Zhi-Cheng; Wu Sao-Mao; Li Wen-Zhu
Journal:  Mycopathologia       Date:  2005-11       Impact factor: 2.574

4.  Clinico-mycological profile of dermatophytosis in a reference centre for leprosy and dermatological diseases in Addis Ababa.

Authors:  Y Woldeamanuel; R Leekassa; E Chryssanthou; Y Mengistu; B Petrini
Journal:  Mycopathologia       Date:  2006-03       Impact factor: 2.574

5.  Onychomycosis in north-East of iran.

Authors:  Parvaneh Afshar; Sadegh Khodavaisy; Shamsi Kalhori; Maryam Ghasemi; Taraneh Razavyoon
Journal:  Iran J Microbiol       Date:  2014-04

6.  Methodology Series Module 2: Case-control Studies.

Authors:  Maninder Singh Setia
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

7.  Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers. A cross sectional - observational study.

Authors:  Gamze Akkus; Mehtap Evran; Dilek Gungor; Mehmet Karakas; Murat Sert; Tamer Tetiker
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

8.  Epidemiology of Dermatophyte and Non-Dermatophyte Fungi Infection in Ethiopia.

Authors:  Shambel Araya; Betelhem Tesfaye; Desalegn Fente
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-04-08

9.  Antifungal mode of action of macrocarpal C extracted from Eucalyptus globulus Labill (Lan An) towards the dermatophyte Trichophyton mentagrophytes.

Authors:  Jack Ho Wong; Kit-Man Lau; Yu-On Wu; Ling Cheng; Chun-Wai Wong; David Tai-Wai Yew; Ping-Chung Leung; Kwok-Pui Fung; Mamie Hui; Tzi-Bun Ng; Clara Bik-San Lau
Journal:  Chin Med       Date:  2015-11-21       Impact factor: 5.455

10.  Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in Tunisia.

Authors:  Nourchène Toukabri; Cyrine Dhieb; Dalenda El Euch; Mustapha Rouissi; Mourad Mokni; Najla Sadfi-Zouaoui
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-08-09       Impact factor: 2.471

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.